Insider trades

Gilead Raday, COO of RedHill Biopharma RDHL, has filed 0 purchases and 1 sale on the open market. Over the past 12 months that comes to a net purchase of $0. The latest trade was on 04/06.

Gilead Raday

COO
First filing
26/04/22
Trades
2 trades
Buys / sales
0 / 1
12-month net buying
$0
Last trade
04/06

Trading activity

Transactions

Trade type
Open-market sale04/0604/2215,740,000 sh$0.00$0−5.7%